Healthcare
Tuesday, May 17, 2016
BRIEF-Immunicum signs clinical development services agreement with US-based Accelovance
* Says engages US based Accelovance and the Midwest Melanoma Partnership (MMP) to evaluate
INTUVAX and to advance the Clinical Studies Pipeline into the US
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment